CX Institutional Has $9.33 Million Position in Cigna Group $CI

CX Institutional grew its position in Cigna Group (NYSE:CI) by 5.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,831 shares of the health services provider’s stock after purchasing an additional 1,832 shares during the period. CX Institutional’s holdings in Cigna Group were worth $9,326,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC raised its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the period. Sivia Capital Partners LLC grew its position in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares during the period. NewEdge Advisors LLC grew its position in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after purchasing an additional 958 shares during the period. Treasurer of the State of North Carolina increased its stake in Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after purchasing an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in Cigna Group during the 2nd quarter worth approximately $163,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Trading Up 1.2%

Shares of NYSE:CI opened at $282.27 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company’s 50-day moving average price is $286.54 and its two-hundred day moving average price is $281.21. The stock has a market capitalization of $74.59 billion, a PE ratio of 11.68, a price-to-earnings-growth ratio of 1.07 and a beta of 0.29. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts forecast that Cigna Group will post 30.5 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Transactions at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Barclays upped their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday. Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. UBS Group upped their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $340.60.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.